Pharmaceutical Microbiology Group

Oliver Gordon from Novartis Pharma becomes new Advisory Board Member

<< Back to overview <<

Oliver Gordon.In February, Oliver Gordon was appointed to the Advisory Board of ECA's Rapid Microbiological Working Group. Oliver Gordon studied Molecular Biology (main focus in Microbiology and Infection Biology) at the Biocenter and the University Hospital in Basel, Switzerland. His research focused on novel implant coating strategies for prevention of post-operative infection and the interactions between the contaminating micro-organisms, the antimicrobial coating substance and the host cells. Since 2010 he has been working at Novartis Pharma AG in Switzerland in the QA/QC-Microbiology department in the Launch Center for Rapid Microbiological Methods. As Rapid Microbiology Specialist he is playing a leading role in the evaluation and validation of Rapid Microbiological Methods and the subsequent replacement of Traditional Microbiological Methods, including method transfer for interested Novartis sites worldwide.

<< Back to overview <<

Imprint   .   Privacy Policy   .   Contact us